The Pediatric Neurology Service organizes the congress "From the genome to precision medicine in pediatric movement disorders", with the aim of exposing the treatments and the main lines of research in these pathologies. The congress will take place on November 30 and December 1 at Hotel Alimara.Pediatric movement disorders are rare diseases that cause severe problems such as dystonia (involuntary contraction of muscular groups and anomalous postures), myoclonus (another type of involuntary movement, shorter and more sudden) and often a physical disability that limits independence and quality of life in patients. The congress https://sites.google.com/view/permedpediamovementdisorders/home "From the genome to precision medicine in pediatric movement disorders" is a meeting point for professionals and patients' relatives in order to share the most recent advances in this field.These pathologies start at an early age and have a genetic cause. For this reason, as Dr. Belén Pérez Dueñas, of the Pediatric Neurology Service, points out "we must continue advancing in the knowledge of the genetics of these pathologies". In this sense, gene therapies are beginning to develop. "Clinical trials are already under way, but there are no approved therapies of this kind for movement disorders. These are therapies that aim to correct the genetic defect caused by the disease. In some pathologies it is a single gene, in others there are several genes".Vall d'Hebron Hospital and Vall d'Hebron Research Institute (VHIR) are leading research in this field, with the participation of numerous professionals in national and international projects. As Dr. Alfons Macaya, of the Pediatric Service and coordinator of the http://en.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186880 Pediatric Neurology Research Group at VHIR, states "The complexity of the genetics of these disorders, in which alterations of multiple genes involved in nerve transmission converge, poses a diagnostic challenge. At the same time, it is essential to apply precision medicine in these cases, both in the selection of drugs and in the development of advanced therapies aimed at counteracting the effect of specific mutations."Currently, neuromodulation is a very effective symptomatic treatment in these movement disorders. "The electrical activity of the brain is modulated with electrodes placed in specific regions of this organ which generate an electrical current that seeks to inhibit unwanted movements", explains Dr. Pérez Dueñas. Depending on the person and pathology, this type of treatment can eliminate up to 50-80% of the symptoms, "which significantly improves the quality of life of the patients", adds this expert.During the congress, there will be genetics and neuromodulation workshops for neuropediatricians to know in depth the advances in these diagnostic and therapeutic techniques. The associations of families of children with movement disorders will be the protagonists during the second day and will be able to express the difficulties they face in their daily life.